Combination Therapy for Hypertension

Rationale for Combination Therapy

• The European Society of Cardiology recommends the combination of an ACE inhibitor (like captopril) and a dihydropyridine calcium channel blocker (like amlodipine) as one of the preferred combinations for treating hypertension 1, 2
• This combination provides complementary mechanisms of action that result in more effective blood pressure reduction than either medication alone 3
• Current guidelines recommend combination therapy as initial treatment for most patients with confirmed hypertension (BP ≥140/90 mmHg) 1, 4
• Fixed-dose single-pill combinations containing these medication classes are available and recommended to improve adherence 5, 4

Benefits of This Specific Combination

• The combination of an ACE inhibitor and calcium channel blocker has demonstrated effective reduction of blood pressure and cardiovascular events 1, 2
• When combined, these medications can allow for lower doses of each individual drug, potentially reducing side effects while maintaining efficacy 3
• This combination targets different blood pressure control mechanisms: ACE inhibitors block the renin-angiotensin system while calcium channel blockers affect calcium-dependent vascular smooth muscle contraction 6

Administration Considerations

• The European Society of Cardiology recommends taking medications at the most convenient time of day for the patient to establish a habitual pattern of medication taking to improve adherence 1, 4

Important Cautions

• The American College of Cardiology and European Society of Cardiology note that combining two RAS blockers (such as an ACE inhibitor with an ARB) is not recommended 1, 4, 7

Combination Therapy for Hypertension Management

Clinical Guidelines and Recommendations

• The JNC 7 guidelines specifically list amlodipine-lisinopril as an available fixed-dose combination for hypertension management 8, 9
• The American College of Cardiology recommends that most patients with hypertension, especially black patients, require 2 or more antihypertensive medications to achieve adequate BP control 10

Patient Populations and Efficacy

• In the ALLHAT study, which involved more than 40,000 hypertensive individuals, both lisinopril and amlodipine were effective in lowering blood pressure 9
• For patients with chronic kidney disease, the combination of lisinopril and amlodipine may provide additional benefits, as ACE inhibitors are recommended for patients with albuminuria or renal dysfunction 11

Safety Considerations

• Black patients may have a higher risk of angioedema with ACE inhibitors, and Asian Americans have a higher incidence of ACE inhibitor-induced cough 10